Peer-Reviewed Publications

      Addressing traceability of self-reported dependence measurement through the use of crosswalks

      Salzberger, T.; Cano, S.; Abeth-Webb, L.; Afolalu, E; Chrea, C.; Weitkunat, R.; Rose, J.
      Published
      May 17, 2021
      DOI
      10.1016/j.measurement.2021.109593
      Link to publication
      Topic
      Summary

      Measurement in the social sciences has been characterized by deficient justification and underdeveloped conceptual theories. Instruments supposed to measure the same measurand typically do not provide comparable measurements. From the perspective of metrological traceability, the state of affairs has thus been unsatisfactory. Today, better instruments can be developed as psychometrics provides tools for invariant measurement (Rasch measurement theory), where measurements are justifiable, linear, and sample-independent. Different instruments can be linked to a common metric of the measurand by means of co-calibration of item parameters. Such linkages, referred to as crosswalks, are an important and practically useful contribution to traceability, when common references have not been developed, yet. The measurement of dependence on tobacco and/or nicotine-containing products through self-report instruments illustrates the limitations of traditional measurement, how they can be overcome by new instrument development, and how a network of crosswalks with existing legacy instruments can be established.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.